Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Syros PharmaceuticalsSatsuma PharmaceuticalsMannKindStemline TherapeuticsOsmotica Pharmaceuticals
SymbolNASDAQ:SYRSNASDAQ:STSANASDAQ:MNKDNASDAQ:STMLNASDAQ:OSMT
Price Information
Current Price$7.35$27.18$1.56$6.83$5.85
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$13.83$18.00$2.83$21.50$11.67
% Upside from Price Target88.21% upside-33.77% downside81.62% upside214.79% upside99.43% upside
Trade Information
Market Cap$310.88 million$497.29 million$311.68 million$355.92 million$313.25 million
Beta1.58N/A2.461.43N/A
Average Volume151,48153,4342,288,950552,920388,534
Sales & Book Value
Annual Revenue$2.05 millionN/A$27.86 million$500,000.00$263.70 million
Price / Sales152.16N/A11.56684.781.14
CashflowN/AN/AN/AN/A$3.03 per share
Price / CashN/AN/AN/AN/A1.93
Book Value$2.34 per shareN/A($1.10) per share$1.32 per share$7.50 per share
Price / Book3.14N/A-1.425.170.78
Profitability
Net Income$-62,280,000.00N/A$-86,970,000.00$-85,020,000.00$-109,400,000.00
EPS($1.91)N/A($0.59)($2.99)($0.51)
Trailing P/E RatioN/A0.00N/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-3,115.38%N/A-75.13%N/A-142.64%
Return on Equity (ROE)-84.49%N/AN/A-80.29%-42.38%
Return on Assets (ROA)-60.09%N/A-49.16%-65.23%-18.25%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.20%N/AN/AN/A1.92%
Current Ratio4.92%N/A0.96%8.75%2.13%
Quick Ratio4.92%N/A0.90%8.63%1.78%
Ownership Information
Institutional Ownership PercentageN/A77.24%26.50%85.98%3.84%
Insider Ownership Percentage14.80%45.65%1.02%13.10%4.70%
Miscellaneous
Employees761122592466
Shares Outstanding42.44 million17.38 million206.41 million50.13 million51.52 million
Next Earnings Date3/5/2020 (Estimated)2/25/2020 (Estimated)2/25/2020 (Confirmed)3/20/2020 (Estimated)3/25/2020 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel